Jane Street Group, LLC Kala Pharmaceuticals, Inc. Transaction History

Jane Street Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$0.3 - $1.31 $15,884 - $69,361	-52,948 Reduced 44.14%	67,015 $20,000
Q1 2022 May 17, 2022	BUY	$0.61 - $1.84 $61,968 - $186,920	101,587 Added 552.82%	119,963 $166,000
Q4 2021 Feb 15, 2022	BUY	$1.16 - $2.74 $2,009 - $4,745	1,732 Added 10.41%	18,376 $22,000
Q2 2021 Aug 16, 2021	SELL	$5.06 - $8.15 $188,429 - $303,497	-37,239 Reduced 69.11%	16,644 $88,000
Q1 2021 May 18, 2021	BUY	$6.24 - $9.58 $110,635 - $169,853	17,730 Added 49.04%	53,883 $363,000
Q3 2020 Nov 17, 2020	BUY	$7.5 - $11.11 $177,862 - $263,473	23,715 Added 190.67%	36,153 $271,000
Q2 2020 Aug 17, 2020	BUY	$8.33 - $13.79 $103,608 - $171,520	12,438 New	12,438 $130,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $9.96M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.